Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Carcinoma × Narrow Band Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 7 Stomach Neoplasms 4 Barrett Esophagus 3 Polyps 2 Neoplasms 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Colonic Polyps 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Adenomatous Polyps 2 Adenoma 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Papilloma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Margins of Excision 1 Laryngeal Diseases 1 Inflammatory Bowel Diseases 1 Hypopharyngeal Neoplasms 1 Hypersensitivity 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

Cisplatin 121 Gemcitabine 67 Radiotherapy, Intensity-Modulated 58 Docetaxel 36 toripalimab 34 Fluorouracil 34 Capecitabine 34 Radiotherapy 21 Drug Therapy 20 camrelizumab 19 nimotuzumab 18 spartalizumab 12 pembrolizumab 12 nedaplatin 12 apatinib 11 Induction Chemotherapy 11 sintilimab 10 Chemoradiotherapy 10 tislelizumab 9 Magnetic Resonance Spectroscopy 9 Carboplatin 9 Specimen Handling 8 Radiation 8 Nivolumab 8 Cetuximab 8 Bevacizumab 8 endostar protein 7 Paclitaxel 7 Immune Checkpoint Inhibitors 7 Endostatins 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04593186 2023-09-07

Magnifying NBI for Occult NPC

Chinese University of Hong Kong

Phase NA Unknown

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡